A Randomized, Double‐Blind, Placebo‐Controlled Study to Evaluate the Effect of Erenumab on Exercise Time During a Treadmill Test in Patients With Stable Angina

OBJECTIVE: To determine the potential impact of erenumab, a human anti‐calcitonin gene‐related peptide (CGRP) receptor monoclonal antibody, on total exercise time (TET), time to exercise‐induced angina, and ST depression in a double‐blind, placebo‐controlled study in patients with stable angina due...

Descripción completa

Detalles Bibliográficos
Autores principales: Depre, Christophe, Antalik, Lubomir, Starling, Amaal, Koren, Michael, Eisele, Osaro, Lenz, Robert A., Mikol, Daniel D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Submissions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001517/
https://www.ncbi.nlm.nih.gov/pubmed/29878340
http://dx.doi.org/10.1111/head.13316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001517/
https://www.ncbi.nlm.nih.gov/pubmed/29878340
http://dx.doi.org/10.1111/head.13316

Ejemplares similares